MoneyWorks4Me

USFDA completes cGMP inspection at Marksans Pharma’s Goa facility

10 Nov 2025 Evaluate

The U.S. Food and Drug Administration (USFDA) has completed a current Good Manufacturing Practice (cGMP) inspection at the 2nd manufacturing facility of Marksans Pharma located at Verna, Goa. The inspection was held between November 03, 2025 to November 07, 2025. At the conclusion of the inspection, the USFDA issued zero from 483 observation.

Marksans Pharma is engaged in Research, Manufacturing & Marketing of generic pharmaceutical formulation in the global markets.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..